Work

Nanofiber-expanded human umbilical cord blood-derived CD34+ stem cell-mediated wound healing and underlying mechanisms

Year: 2013
Type: article
Abstract: Wound healing requires a well-orchestrated integration of complex biological and molecular events include inflammation, cell proliferation, cell migration, angiogenesis, extra cellular matrix (ECM) production, and remodeling.Impairment of this orchestrated process results in development of chronic wounds in pathological conditions like diabetes.Despite advancements in wound care over 72,000 amputations occur in each year in diabetic patients related to refractory wounds.Current medical interventions, such as systemic (e.g.Hyperbaric oxygen therapy) or topical (e.g.Growth factor; PDGF) therapy could not prevent lower limb amputations related to chronic wounds.Systemic or local stem cell therapy might be an alternative approach to treat refractory wounds.Adult stem cells expressing CD133/CD34 surface marker are multipotent cells that can be isolated from human umbilical cord blood and undergo the self-renewal process.However, limited numbers in a single cord blood unit restricts their experimental and clinical use.Our laboratory has developed a nanofiber-based expansion technology to achieve adequate numbers of human umbilical cord blood derived CD34 + cells for experimental use, and for potential use for therapeutic applications.Using an excisional wound model in nonobese diabetic severe combined immunodeficient (NOD/SCID) mice, herein, we show that CD34 + cells home to the wound site after systemic administration and significantly accelerate wound closure.Histological analysis revealed that accelerated wound closure was associated with increased granulation tissue
Author: Suman Kanji
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: green
OpenAlex ID: W2606252811
FWCI:
Cites: 227
Cited by:
Related to: 10